Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-07 @ 3:33 AM
Study NCT ID:
NCT05567458
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-12
First Post:
2022-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-03
First Submit QC Date:
None
Study First Post Date:
2022-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-07
Last Update Post Date:
2025-08-12
Last Update Post Date Type:
ACTUAL